Kaposi's sarcoma-associated herpesvirus at 27
Marta Gaglia
Abstract
Kaposi's sarcoma-associated herpesvirus (KSHV) was discovered 27 years ago and its link to several pathologies - Kaposi's sarcoma, primary effusion lymphoma, and the B cell variant of Multicentric Castleman disease - is now well established. However, many questions remain about how KSHV causes tumors. Here, I will review studies from the last few years (primarily 2019-2021) that report new information about KSHV biology and tumorigenesis, including new results about KSHV proteins implicated in tumorigenesis, genetic and environmental variability in KSHV-related tumor development, and potential vulnerabilities of KSHV-caused tumors that could be novel therapeutic targets.
Topics & Concepts
Primary effusion lymphomaCarcinogenesisKaposi's sarcoma-associated herpesvirusSarcomaLymphomaVirologyBiologyCancer researchVirusPathologyImmunologyMedicineHerpesviridaeCancerViral diseaseGeneticsViral-associated cancers and disordersCytomegalovirus and herpesvirus researchHistiocytic Disorders and Treatments